Advanced therapy is delayed in pediatric South Asian inflammatory bowel disease patients in the United States
SA pIBD had unique phenotypic characteristics compared to NSA pIBD. SA pIBD patients were less likely to initiate biologic therapies as their initial treatment and had a longer time-to-initiation of biologic therapies.
Authors
- Megha Tandon (ORCID: https://orcid.org/0000-0001-9999-5332)
- Sushrut Jangi (ORCID: https://orcid.org/0000-0001-5488-5770)
- Lauren V. Collen (ORCID: https://orcid.org/0000-0002-7769-8123)
- Nurgul Yegembayeva (ORCID: https://orcid.org/0009-0008-1853-3194)
- Jennifer Bachand
Institutions
- Tufts University (US)
- Boston Children's Hospital (US)
- Tufts Medical Center (US)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1002/jpn3.70233
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00